¡¡
Pharma Koreana, Korea pharmaceutical news & reports, was established in 1991 and is now Korean leading pharmaceutical business newsletter. For the past years, Pharma Koreana has consistently provided senior executives in the pharmaceutical industry with the inside knowledge they need to compete and win! Readers are subscribers at the pinnacle of their careers as well as the rising stars of tomorrow. They turn to Pharma Koreana for its unique monthly package of Korean pharmaceutical news, analyses, commentaries and data. ¡¡
          
¡¡

News search results
There are '2475' news items matching your search for 'Bio industry news'

1. Hanwha Chemical completes a phase I clinical trial for a biosimilar version of Enbrel

Hanwha Chemical recently announced that it successfully completed a phase I clinical trial for HD203, a biosimilar version of Enbrel (etaner ..
 

August 31st, 2010
2. Neuronex develops a micro powder formulation to dilate peripheral vessels

Neuronex, a local bio-venture company, recently announced that it has successfully developed a micro powder formulation of NXCL-4950, its pa ..
 

August 31st, 2010
3. SK Chemicals to introduce the latest technology for vaccines from Xcellerex of the U.S.

SK Chemicals recently signed a comprehensive collaboration MOU with Xcellerex Inc. (the U.S.). Xcellerex has developed novel technologies fo ..
 

August 24th, 2010
4. Bio Korea 2010 to be held

The Korea Health Industry Development Institute (KHIDI) announced that ¡®Bio Korea 2010, Conference & Exhibition¡¯ will be held in Seoul b ..
 

August 24th, 2010
5. Total output in the bio-industry recorded 14% increase in 2009

The Korea Biotechnology Industry Organization (KOREABIO) selected 100 companies (the top 60 companies in terms of production value, the top ..
 

August 24th, 2010
6. Single molecule suppressing not only tumor growth but also metastasis developed

The joint research team of Professor KOH Gou-young of the Korea Advanced Institute of Science and Technology (KAIST) and Professor NAM Do-hy ..
 

August 24th, 2010
7. Seegene achieved sales growth of 145.4% in the first half of 2010

Seegene, a biotechnology company based in Seoul, Korea, and Rockville, MD, USA, announced that the company achieved sales of 11.16 billion w ..
 

August 24th, 2010
8. Macrogen and LG Life Sciences sign strategic alliance MOU for theranostics

Macrogen, a local biotechnology firm, and LG Life Sciences recently signed a comprehensive collaboration MOU for R&D and commercializati ..
 

August 17th, 2010
9. RNL Bio completes a phase I clinical trial for a stem cell-based therapy for the treatment of spinal cord injury

RNL Bio, a local bio-company, completed a phase I clinical trial for RNL-Astrostem, an adult stem cell-based therapy for the treatment of sp ..
 

August 17th, 2010
10. Reyon files an IND application for a phase I clinical trial for a DNA-based therapeutic cancer vaccine

Reyon Pharm recently filed an Investigational New Drug (IND) application for a phase I clinical trial for VM206RY, a DNA-based therapeutic ..
 

August 17th, 2010
11. Cho-A successfully clones transgenic pigs

Cho-A Pharm recently announced that it successfully cloned two transgenic pigs carrying a human growth hormone (hGH) gene. The firm has perf ..
 

August 17th, 2010
12. RNL Bio to conquer cancer by using stem cells

RNL Bio, a local bio-company, recently announced that it confirmed inhibitory effects of fat-derived stem cells on cancer cells in its joi ..
 

August 10th, 2010
13. Hanmi¡¯s clinical trials for a once-monthly antidiabetic successfully underway

Hanmi Pharm announced that its phase I clinical trials for HM11260C, the world¡¯s first once-monthly diabetic drug, is successfully underway ..
 

August 10th, 2010
14. Korea Green Cross successfully commercializes an albumin-free recombinant coagulation factor VIII

Korea Green Cross recently announced that it received the KFDA approval for GreenGene F inj., a third-generation recombinant coagulation fac ..
 

August 10th, 2010
15. Seegene introduces two diagnostic test kits for sepsis and tuberculosis

Seegene, a biotechnology company based in Seoul, Korea, and Rockville, MD, USA, recently introduced Magicplex Sepsis Test and Anyplex MDR-TB ..
 

August 3rd, 2010
[1] 2 3 4 5 6 7 8 9 10
¡¡
Pharma Koreana Ltd. 14th floor, KTB Network Bldg., 826-14, Yeoksam, Kangnam-gu, Seoul135-080 ,KOREA Tel:(82)2-554-9591 Fax:(82)2-563-8289 ¡¡ ¡¡

Email:Pkinfo@Pharmakoreana.com
Subscriptions:Pkinfo@Pharmakoreana.com
¡¡
¡¡